Tetanus toxin monoclonal antibody (Changchun Baike)
全人源抗破伤风毒素单克隆抗体（长春百克）
Report date: 2024/05/15 20:00:35
Base Information
Drug NameTetanus toxin monoclonal antibody (Changchun Baike)
Drug Alias Name
Classification
Mechanisms of Action
Targets
Therapy Area/Indications
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/Territory
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaPhase 2 Clinical
Originator CompaniesChangchun Bcht Biotechnology Co
China Registration ClassClass 1 therapeutic biologic in China
Develop Information
Active CompaniesChangchun Bcht Biotechnology Co
Inactive CompaniesN/A
Active Indications
Inactive IndicationsN/A
Other Information
ATC CodeN/A
Related LinksN/A